Guaifenesin And Pseudoephedrine Hcl Tablet, Extended Release
Product Images NDC 62207-827

4 FDA label images from Granules India Ltd · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Guaifenesin And Pseudoephedrine Hcl (NDC 62207-827). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules India Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ggf-pseudo-600mg-60mg-foil-label (Ggf Pseudo 600mg 60mg Foil Label)

Ggf-pseudo-600mg-60mg-foil-label (Ggf Pseudo 600mg 60mg Foil Label)
Label for Guaifenesin and Pseudoephedrine HCl Extended-Release Tablet, 600 mg and 60 mg. The label states it is an expectorant and nasal decongestant that relieves nasal and chest congestion. Manufactured by Granules India Limited, made in India. The label includes instructions to push the tablet through foil and has space for lot number and expiration date. NDC 62207-827-72 is shown with a 12-hour extended-release symbol.*
FDA Label Image

Ggf-pseudo-600mg-60mg-blistercarton (Ggf Pseudo 600mg 60mg Blistercarton)

Ggf-pseudo-600mg-60mg-blistercarton (Ggf Pseudo 600mg 60mg Blistercarton)
The packaging label for Guaifenesin and Pseudoephedrine Hydrochloride Extended-Release Tablets displays strengths of 600 mg and 60 mg. The oral dosage form is for nasal and chest congestion relief. The box contains 90 extended-release tablets (9x10). It includes drug facts detailing active ingredients, uses, warnings, directions, inactive ingredients, and manufacturer information. Manufactured by Granules India Limited and distributed by Granules USA, Inc., the label shows the NDC 62207-827-72 and highlights a 12-hour release time.*
FDA Label Image

Ggf-pseudo-1200mg-120mg-foil-label (Ggf Pseudo 1200mg 120mg Foil Label)

Ggf-pseudo-1200mg-120mg-foil-label (Ggf Pseudo 1200mg 120mg Foil Label)
Label for Guaifenesin and Pseudoephedrine HCl extended-release tablets, maximum strength 1200 mg and 120 mg. The label highlights the product as an expectorant and nasal decongestant that relieves nasal and chest congestion. Manufacturer is Granules India Limited, with instructions to push the tablet through foil. The label also includes an NDC code 62207-828-71, a 12-hour duration symbol, and spaces for lot number and expiration date.*
FDA Label Image

Ggf-pseudo-1200mg-120mg-blistercarton (Ggf Pseudo 1200mg 120mg Blistercarton)

Ggf-pseudo-1200mg-120mg-blistercarton (Ggf Pseudo 1200mg 120mg Blistercarton)
Packaging label for Guaifenesin and Pseudoephedrine Hydrochloride Extended-Release Tablets, 1200 mg and 120 mg strength. The label states the product is an oral tablet for nasal and chest congestion relief, containing 70 (7x10) extended-release tablets. Manufactured by Granules India Limited and distributed by Granules USA, Inc. The label includes dosage, usage information, and drug facts.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.